Cyclo Therapeutics, Inc. (CYTH)
NASDAQ: CYTH · Real-Time Price · USD
0.630
+0.010 (1.61%)
Dec 20, 2024, 4:00 PM EST - Market closed

Cyclo Therapeutics Revenue

Cyclo Therapeutics had revenue of $233.77K in the quarter ending September 30, 2024, a decrease of -52.82%. This brings the company's revenue in the last twelve months to $870.73K, down -8.52% year-over-year. In the year 2023, Cyclo Therapeutics had annual revenue of $1.08M, down -21.76%.

Revenue (ttm)
$870.73K
Revenue Growth
-8.52%
P/S Ratio
19.56
Revenue / Employee
$108,841
Employees
8
Market Cap
18.12M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.08M-299.36K-21.76%
Dec 31, 20221.38M-210.00K-13.24%
Dec 31, 20211.59M682.38K75.54%
Dec 31, 2020903.38K-103.82K-10.31%
Dec 31, 20191.01M-4.28K-0.42%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.